Giapreza Injection
Product Images NDC 68547-501

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Giapreza (NDC 68547-501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by La Jolla Pharmaceutical Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1ml-vial-carton (1 mL Vial Carton)

Packaging label for Giapreza (angiotensin II) injection, 2.5 mg/mL, manufactured by La Jolla Pharmaceutical Company. The label states the product comes in a 1 mL single-dose vial, must be diluted prior to intravenous infusion, and is sterile. Storage instructions indicate refrigeration between 2°C and 8°C (36°F and 46°F). The label includes barcodes, dosage information, and the manufacturer's address in San Diego, CA.*

FDA Label Image

1ml-vial (1 mL Vial)

Label for Giapreza (angiotensin II) Injection 2.5 mg/mL. The label states it contains angiotensin II acetate equivalent to 2.5 mg, is a single-dose vial for intravenous infusion, and is Rx only. Manufactured by La Jolla Pharmaceutical Company, San Diego, CA. Storage instructions specify 2°C to 8°C. The label includes barcode, lot number, and expiration date fields.*

FDA Label Image

Giapreza Forest Plot

Forest plot chart depicting odds ratios and 95% confidence intervals comparing the efficacy of Giapreza (angiotensin II) injection versus placebo across various patient subgroups. The subgroups include age, gender, race, baseline BMI, geographical location, baseline MAP, APACHE II score, dialysis status, creatinine clearance, ARDS X-ray status, history of ACEI or ARB use, albumin levels, and norepinephrine equivalency. The chart shows the number and percentage of patients in the Giapreza and placebo groups for each category, with most odds ratios favoring Giapreza.*

FDA Label Image

Giapreza Structure

Chemical structure diagram of angiotensin II, the active ingredient in Giapreza injection. The image shows the detailed molecular structure with bonds and functional groups clearly illustrated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.